These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34878495)

  • 21. Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records.
    Zema CL; Valdecantos WC; Weiss J; Krebs B; Menter AM
    JAMA Dermatol; 2022 Oct; 158(10):1142-1148. PubMed ID: 35947363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review.
    Sanchez IM; Sorenson E; Levin E; Liao W
    Dermatol Ther (Heidelb); 2017 Dec; 7(4):425-446. PubMed ID: 29143230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database.
    Kubota K; Kamijima Y; Sato T; Ooba N; Koide D; Iizuka H; Nakagawa H
    BMJ Open; 2015 Jan; 5(1):e006450. PubMed ID: 25588781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interventions for chronic palmoplantar pustulosis.
    Marsland AM; Chalmers RJ; Hollis S; Leonardi-Bee J; Griffiths CE
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD001433. PubMed ID: 16437433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics, genetics, comorbidities and treatment of palmoplantar pustulosis: A retrospective analysis of 66 cases in a single center in Taiwan.
    Huang CM; Tsai TF
    J Dermatol; 2020 Sep; 47(9):1046-1049. PubMed ID: 32613680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demographic, clinical, and scintigraphic comparison of patients affected by palmoplantar pustulosis and severe acne: a retrospective study.
    Li Y; Li C; Wu N; Li F; Wu Z; Sun X; Li Q; Li L
    Clin Rheumatol; 2020 Jun; 39(6):1989-1996. PubMed ID: 31953569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pack-year cigarette smoking affects the course of palmoplantar pustulosis.
    Putra-Szczepaniak M; Reich A; Jankowska-Konsur A; Czarnecka A; Bagłaj-Oleszczuk M; Hryncewicz-Gwóźdź A
    Adv Clin Exp Med; 2021 Feb; 30(2):189-195. PubMed ID: 33636060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. General Characteristics and Comorbidities in Patients with Palmoplantar Pustulosis.
    Misiak-Galazka M; Wolska H; Galazka A; Kwiek B; Rudnicka L
    Acta Dermatovenerol Croat; 2018 Jun; 26(2):109-118. PubMed ID: 29989866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful Use of Tildrakizumab for Treatment of Palmoplantar Pustulosis: A Case Report.
    Del Campo DC
    J Drugs Dermatol; 2021 Oct; 20(10):1117-1119. PubMed ID: 34636515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Characteristics of Japanese Patients with Palmoplantar Pustulosis.
    Yamamoto T
    Clin Drug Investig; 2019 Mar; 39(3):241-252. PubMed ID: 30632109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics and health-care resource utilization in patients with generalized pustular psoriasis using real-world evidence from the Japanese Medical Data Center database.
    Okubo Y; Kotowsky N; Gao R; Saito K; Morita A
    J Dermatol; 2021 Nov; 48(11):1675-1687. PubMed ID: 34390028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. UVA1 phototherapy in the treatment of palmoplantar pustulosis: a pilot prospective study.
    Su LN; Xu X; Tang L; Yu N; Ding YF
    Lasers Med Sci; 2016 Nov; 31(8):1641-1643. PubMed ID: 27437986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guselkumab for the treatment of palmoplantar pustulosis.
    Murakami M
    Expert Opin Biol Ther; 2020 Aug; 20(8):841-852. PubMed ID: 32321322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nail involvement features in palmoplantar pustulosis.
    Kim M; Yang S; Kim BR; Youn SW
    J Dermatol; 2021 Mar; 48(3):360-365. PubMed ID: 33305841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful Treatment of Palmoplantar Pustulosis With Apremilast.
    Dorgham N; Crasto D; Skopit S
    J Drugs Dermatol; 2021 Nov; 20(11):1255-1256. PubMed ID: 34784120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicentre open-label study of apremilast in palmoplantar pustulosis (APLANTUS).
    Wilsmann-Theis D; Kromer C; Gerdes S; Linker C; Magnolo N; Sabat R; Reich K; Mössner R
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):2045-2050. PubMed ID: 34077577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life and comorbidities in palmoplantar pustulosis - a cross-sectional study on 102 patients.
    Trattner H; Blüml S; Steiner I; Plut U; Radakovic S; Tanew A
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1681-1685. PubMed ID: 28252813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary habits in Japanese patients with palmoplantar pustulosis.
    Serizawa N; Okazaki S; Otsuka Y; Koto M; Okabe K; Ito M; Morita T; Hoashi T; Saeki H; Abe N; Mori M; Okubo Y; Yano Y; Mitsui H; Kanda N
    J Dermatol; 2021 Mar; 48(3):366-375. PubMed ID: 33404125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immediate response to apremilast in patients with palmoplantar pustulosis: a retrospective pilot study.
    Kato N; Takama H; Ando Y; Yanagishita T; Ohshima Y; Ohashi W; Akiyama M; Watanabe D
    Int J Dermatol; 2021 May; 60(5):570-578. PubMed ID: 33454961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Features, Etiologic Factors, Associated Disorders, and Treatment of Palmoplantar Pustulosis: The Mayo Clinic Experience, 1996-2013.
    Olazagasti JM; Ma JE; Wetter DA
    Mayo Clin Proc; 2017 Sep; 92(9):1351-1358. PubMed ID: 28764899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.